Comparison of Survival Outcomes following Segmental Bile Duct Resection versus Pancreatoduodenectomy for Mid Bile Duct Cancer
![]() |
Seo, Seok-In
(Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine)
Hwang, Shin (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Lee, Young-Joo (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Kim, Ki-Hun (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Ahn, Chul-Soo (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Moon, Deok-Bog (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Ha, Tae-Yong (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Song, Gi-Won (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Jung, Dong-Hwan (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Park, Kwang-Min (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Hwang, Dae-Wook (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) Lee, Sung-Gyu (Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 2005;241:77-84. |
2 | Chamberlain RS, Blumgart LH. Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 2000;7:55-66. DOI ScienceOn |
3 | Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993;128:871-877. DOI ScienceOn |
4 | Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997;15:947-954. DOI |
5 | Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996;224:628-638. DOI ScienceOn |
6 | Allen PJ, Reiner AS, Gonen M, et al. Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB (Oxford) 2008;10:341-346. DOI ScienceOn |
7 | Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-473. DOI ScienceOn |
8 | Tompkins RK, Thomas D, Wile A, Longmire WP Jr. Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg 1981;194:447-457. DOI ScienceOn |
9 | Heron DE, Stein DE, Eschelman DJ, et al. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome. Am J Clin Oncol 2003;26:422-428. |
10 | Todoroki T, Kawamoto T, Koike N, Fukao K, Shoda J, Takahashi H. Treatment strategy for patients with middle and lower third bile duct cancer. Br J Surg 2001;88:364-370. DOI ScienceOn |
11 | Gwak HK, Kim WC, Kim HJ, Park JH. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy. Int J Radiat Oncol Biol Phys 2010;78: 194-198. DOI ScienceOn |
12 | Reding R, Buard JL, Lebeau G, Launois B. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg 1991;213: 236-241. DOI ScienceOn |
13 | Hwang S, Lee SG, Kim KH, et al. Extended extrahepatic bile duct resection to avoid performing pancreatoduodenectomy in patients with mid bile duct cancer. Dig Surg 2008;25:74-79. DOI ScienceOn |
14 | Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York: Springer-Verlag; 2002. |
15 | Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003;98:1689-1700. DOI ScienceOn |
16 | Borghero Y, Crane CH, Szklaruk J, et al. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 2008;15: 3147-3156. DOI ScienceOn |
![]() |